Skane University Hospital, Lund
Lund, 22185, Sweden
NCT Number: NCT01413841
Nasal oxygen is widely used as pain relief against ischemic pain during Percutaneous Coronary Intervention (PCI). However, to our knowledge no randomised clinical trials have tested this. In contrast, oxygen causes coronary artery vasoconstriction in man. Furthermore, a recent Cochrane meta-analysis has shown no evidence of beneficial effect of oxygen for patients with acute myocardial infarction (with normal blood saturation. The investigators therefore wanted to examine if oxygen reduces ischemic pain during PCI for stable angina or NSTEMI.
Looking for future studies?
Notify MeAll sexes
Interventional
Phase 2
Lund, 22185, Sweden
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3 l oxygen
3 l nasal air
Time frame: 1 h
After PCI patient is asked in a double blinded about maximum chest during PCI.
Time frame: 2 days
Peak troponin the first days after PCI
Region Skane
Other
Phase II Randomised Study of Nasal Oxygen Treatment for Pain Relief During Percutaneous Coronary Interventions
Acronym: OXYPAIN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06212466
Angina, Angina Pectoris
Gainesville, Florida, United States
View Trial DetailsNCT06139094
Angina, Angina Pectoris
Gainesville, Florida, United States
View Trial DetailsNCT02032030
Angina, Angina Pectoris
St Louis, Missouri, United States
View Trial DetailsNCT04097912
Angina, Angina Pectoris
Multiple Locations, Germany
View Trial Details